Is Formaldehyde the missing link in AD pathology? The differential aggregation of amyloid-beta with APOE isoforms in vitro

Current Alzheimer Research

Volumn 11, Issue 5, 2014, Pages 461-468

  Rizak, Joshua D ^a,b   Ma, Yuanye ^a   Hu, Xintian ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Aggregation; Alzheimer's disease; Amyloid beta; Apolipoprotein E isoforms; Formaldehyde; Plaque formation

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ARGININE; FORMALDEHYDE; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; FIXATIVE; ISOPROTEIN; PEPTIDE FRAGMENT; PROTEIN AGGREGATE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; IN VITRO STUDY; MENTAL HEALTH; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONTENT; RISK FACTOR; WESTERN BLOTTING; DOSE RESPONSE; DRUG EFFECTS; HUMAN; METABOLISM;

AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; DOSE-RESPONSE RELATIONSHIP, DRUG; FIXATIVES; FORMALDEHYDE; HUMANS; PEPTIDE FRAGMENTS; PROTEIN AGGREGATES; PROTEIN ISOFORMS;

EID: 84904065799     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205011666140425112043     Document Type: Article

References (56)

1. Alzheimer's Disease International and the World Health Organization. Dementia: a public health priority. WHO press 2012.
2. Thies W, Bleiler L. Alzheimer's disease facts and figures. Alzheimers Dement 9(2): 208-45 (2013).
3. Bertram L, Tanzi RE. The genetics of Alzheimer's disease. Prog Mol Biol Transl Sci 107: 79-100 (2012).
4. Van Gassen G, Annaert W. Amyloid, presenilins, and Alzheimer's disease. Neuroscientist 9(2): 117-26 (2003).
5. Annaert W, Cupers P, Saftig P, De Strooper B. Presenilin function in APP processing. Ann NY Acad Sci 920: 158-64 (2000).
6. Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 10(3): 241-52 (2011).
7. Youmans K, Tai L, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M, et al. APOE4-specific changes in Aβ accumulation in a new transgenic model of Alzheimer's Disease. J Biol Chem 287(50): 41774-86 (2012).
8. Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3(89): 89ra57 (2011).
9. Tong Z, Han C, Luo W, Wang X, Li H, Luo H, et al. Accumulated hippocampal formaldehyde induces age-dependent memory decline. Age (Dordr) 35(3): 583-96 (2013).
10. Wang W, Hao Z, Zhang L, Li W, Li M, Zhang J, et al. Research on urine formaldehyde concentration in Alzheimer's elderly and normal elderly. Chin J Geriatr Heart Brain Vessel Dis 12: 721-2 (2010).
11. Tong Z, Zhang J, Luo W, Wang W, Li F, Li H, et al. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiol Aging 32(1): 31-41 (2011).
12. He RQ, Lu J, Mia JY. Formaldehyde stress. Science China-Life Sciences 53(12): 1399-404 (2010).
13. Kilburn KH, Warshaw R, Thornton JC. Formaldehyde Impairs Memory, Equilibrium, and Dexterity in Histology Technicians-Effects Which Persist for Days after Exposure. Arch Environ Health 42(2): 117-20 (1987).
14. Li FX, Lu J, Xu YJ, Tong ZQ, Nie CL, He RQ. Formaldehydemediated chronic damage may be related to sporadic neurodegeneration. Progress in Biochemistry and Biophysics 35(4): 393-400 (2008).
15. Chen K, Kazachkov M, Yu PH. Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease. J Neural Transm 114(6): 835-9 (2007).
16. He RQ, Nie CL, Wang XS, Liu Y, S P. Amyloid-like aggregates of neuronal tau are induced by formaldehyde exposure and promote apoptosis of neuronal cells. FASEB J 20: A954-A (2006).
17. Bogdanffy MS, Morgan PH, Starr TB, Morgan KT. Binding of formaldehyde to human and rat nasal mucus and bovine serum albumin. Toxicology Lett 38(1-2): 145-54 (1987).
18. Toews J, Rogalski JC, Clark TJ, Kast J. Mass spectrometric identification of formaldehyde-induced peptide modifications under in vivo protein cross-linking conditions. Analytica chimica acta 618(2): 168-83 (2008).
19. Gardner LA, Desiderio DM, Groover CJ, Hartzes A, Yates CR, Zucker-Levin AR, et al. LC-MS/MS identification of the onecarbon cycle metabolites in human plasma. Electrophoresis 34(11): 1710-6 (2013).
20. Bradford MM. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 72: 248-54 (1976).
21. Gilbert C, Rollet-Labelle E, Caon AC, Naccache PH. Immunoblotting and sequential lysis protocols for the analysis of tyrosine phosphorylation-dependent signaling. J Immunol Methods 271(1-2): 185-201 (2002).
22. Kurien BT, Scofield RH. Nonelectrophoretic bidirectional transfer of a single SDS-PAGE gel with multiple antigens to obtain 12 immunoblots. Methods Mol Biol 536: 55-65 (2009).
23. Garai K, Frieden C. The association-dissociation behavior of the ApoE proteins: kinetic and equilibrium studies. Biochemistry 49(44): 9533-41 (2010).
24. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541(1): 163-6 (1991).
25. Hauser PS, Narayanaswami V, Ryan RO. Apolipoprotein E: from lipid transport to neurobiology. Prog Lipid Res 50(1): 62-74 (2011).
26. Verghese P, Castellano J, Garai K, Wang Y, Jiang H, Shah A, et al. ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc Natl Acad Sci USA 110(19): E1807-16 (2013).
27. Krayukhina E, Uchiyama S, Nojima K, Okada Y, Hamaguchi I, Fukui K. Aggregation analysis of pharmaceutical human immunoglobulin preparations using size-exclusion chromatography and analytical ultracentrifugation sedimentation velocity. J Biosci Bioeng 115(1): 104-10 (2013).
28. Tomar AK, Sooch BS, Singh S, Yadav S. Aggregation analysis of Con A binding proteins of human seminal plasma: a dynamic light scattering study. Intern J Biol Macromol 53(133-7): 133-7.
29. Sweeting JN, Siu M, McCallum GP, Miller L, Wells PG. Species differences in methanol and formic acid pharmacokinetics in mice, rabbits and primates. Toxicol Appl Pharmacol 247(1): 28-35 (2010).
30. Monte W. While Science Sleeps. San Fancisco, USA: Amazon Create Space Publishing; 2011.
31. Johlin FC, Fortman CS, Nghiem DD, Tephly TR. Studies on the role of folic acid and folate-dependent enzymes in human methanol poisoning. Mol Pharmacol 31(5): 557-61 (1987).
32. Hansen JM, Contreras KM, Harris C. Methanol, formaldehyde, and sodium formate exposure in rat and mouse conceptuses: a potential role of the visceral yolk sac in embryotoxicity. Birth Defects Res A Clin Mol Teratol 73(2): 72-82 (2005).
33. Yang M, Lu J, Miao J, Rizak JD, Yang J, Zhai R, et al. Alzheimer's Disease and Methanol Toxicity (Pt. 1): Chronic methanol feeding led to memory impairments and tau hyperphosphorylation in mice. J Alzheimers Dis In Press.
34. Yang M, Miao J, Rizak JD, Zhai R, Wang Z, Anwar TH, et al. Alzheimer's Disease and Methanol Toxicity (Pt. 2): Lessons from four rhesus macaques (macaca mulatta) chronically fed methanol. J Alzheimers Dis In press.
35. Postiglione A, Milan G, Ruocco A, Gallotta G, Guiotto G, Di Minno G. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5, 10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. Gerontology 47(6): 324-9 (2001).
36. Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, et al. S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegenerative disease management. 7: 373-8 (2010).
37. Tyihak E, Albert L, Nemeth ZI, Katay G, Kiraly-Veghely Z, Szende B. Formaldehyde cycle and the natural formaldehyde generators and capturers. Acta Biol Hung 49(2-4): 225-38 (1998).
38. Arlt S, Schwedhelm E, Kolsch H, Jahn H, Linnebank M, Smulders Y, et al. Dimethylarginines, Homocysteine Metabolism, and Cerebrospinal Fluid Markers for Alzheimer's Disease. J Alzheimers Dis. 31(4): 751-8 (2012).
39. Lu J, Miao J, Su T, Liu Y, He R. Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo. Biochim Biophys Acta 1830(8): 4102-16 (2013).
40. Lu J, Miao J, Pan R, He R. Formaldehyde-mediated hyperphosphorylation disturbs the interaction between Tau protein and DNA. Prog Biochem Biophys 38(12): 1113-20 (2011).
41. Beyer K, Lao JI, Latorre P, Riutort N, Matute B, Fernandez-Figueras MT, et al. Methionine synthase polymorphism is a risk factor for Alzheimer disease. Neuroreport14(10): 1391-4 (2003).
42. Gomes Trolin C, Regland B, Oreland L. Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disorders Eur Neuropsychopharmacol 5: 107-14 (1995).
43. Yu PH, Deng YL. Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazidesensitive amine oxidase-mediated methylamine turnover. Atherosclerosis 140(2): 357-63 (1998).
44. Gubisne-Haberle D, Hill W, Kazachkov M, Richardson JS, Yu PH. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Ther 310(3): 1125-32 (2004).
45. Unzeta M, Sole M, Boada M, Hernandez M. Semicarbazidesensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease. J Neural Transm 114(6): 857-62 (2007).
46. Jiang ZJ, Richardson JS, Yu PH. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol App Neurobiol 34(2): 194-204 (2008).
47. Nilsson K, Gustafson L, Hultberg B. Plasma homocysteine and vascular disease in elderly patients with mental illness. Clinical chemistry and laboratory medicine: CCLM/FESCC 46(11): 1556-6 (2008).
48. Koseoglu E, Karaman Y. Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease. Clin Biochem 40(12): 859-63 (2007).
49. Chen KL, Wang SS, Yang YY, Yuan RY, Chen RM, Hu CJ. The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells. Biochem Biophys Res Commun 378(1): 57-61 (2009).
50. Borger E, Aitken L, Du H, Zhang W, Gunn-Moore FJ, Yan SS. Is Amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease? Curr Alzheimer Res 10(1): 21-9 (2013).
51. Liu L, van Groen T, Kadish I, Tollefsbol TO. DNA methylation impacts on learning and memory in aging. Neurobiol Aging 30(4): 549-60 (2009).
52. Patra SK, Patra A, Rizzi F, Ghosh TC, Bettuzzi S. Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development. Cancer Metastasis Rev 27(2): 315-34 (2008).
53. Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 11(9): 607-20 (2010).
54. Im H, Oh E, Mun J, Khim JY, Lee E, Kang HS, et al. Evaluation of toxicological monitoring markers using proteomic analysis in rats exposed to formaldehyde. J Proteome Res 5(6): 1354-66 (2006).
55. Maloney B, Ge YW, Petersen RC, Hardy J, Rogers JT, Perez-Tur J, et al. Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions. Am J Med Genet B Neuropsychiatr Genet 153B(1): 185-201 (2010).
56. Maloney B, Lahiri D. The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif. Gene 488(1-2): 1-12 (2011).